NVCT: Nuvectis Pharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 119.41
Enterprise Value ($M) 100.28
Book Value ($M) 12.20
Book Value / Share 0.69
Price / Book 9.79
NCAV ($M) 12.20
NCAV / Share 0.69
Price / NCAV 9.79

Profitability (mra)
Return on Invested Capital (ROIC) -1.82
Return on Assets (ROA) -1.37
Return on Equity (ROE) -1.81

Liquidity (mrq)
Quick Ratio 2.75
Current Ratio 2.75

Balance Sheet (mrq) ($M)
Current Assets 19.18
Assets 19.18
Liabilities 6.98
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -22.90
Net Income -22.26

Cash Flow Statement (mra) ($M)
Cash From Operations -15.95
Cash from Investing 0.00
Cash from Financing 15.09

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-28 13G/A Mosseri Marlio Charles 15.00 9.03
02-06 13G Pontifax Management 4 G.p. (2015) Ltd. 5.30
02-01 13G/A Shemesh Shay 8.60 23.72
02-01 13G/A Poradosu Enrique 8.70 23.43
01-31 13G/A Peters Thomas Phineas 5.20 -4.13

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q 315603 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 10,621 41,631 25.51
2024-04-18 25,255 69,188 36.50
2024-04-17 12,643 15,269 82.80
2024-04-16 18,453 18,591 99.26
2024-04-15 60,215 27,676 217.57

(click for more detail)

Similar Companies
NRSN – NeuroSense Therapeutics Ltd. NRXP – NRx Pharmaceuticals, Inc.
NTBL – Notable Labs, Ltd. OCEA – Ocean Biomedical, Inc.
OCGN – Ocugen, Inc.


Financial data and stock pages provided by
Fintel.io